SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-106925
Filing Date
2022-04-15
Accepted
2022-04-15 17:23:57
Documents
12
Period of Report
2022-04-15
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d349911d8k.htm   iXBRL 8-K 27745
  Complete submission text file 0001193125-22-106925.txt   146706

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA orgo-20220415.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20220415_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20220415_pre.xml EX-101.PRE 10818
6 EXTRACTED XBRL INSTANCE DOCUMENT d349911d8k_htm.xml XML 3270
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 22830667
SIC: 2834 Pharmaceutical Preparations